Hypermethylated in cancer 1 (HIC1) and slit homolog 2 (SLIT2) were identified as having differentially up-regulated methylation status of their promoter regions and dramatically down-regulated expression level across all the bladder urothelial carcinoma tissue samples. Here, SLIT2 is linked to bladder transitional cell carcinoma.